全文获取类型
收费全文 | 16498篇 |
免费 | 977篇 |
国内免费 | 220篇 |
专业分类
耳鼻咽喉 | 321篇 |
儿科学 | 119篇 |
妇产科学 | 192篇 |
基础医学 | 2865篇 |
口腔科学 | 394篇 |
临床医学 | 1254篇 |
内科学 | 3023篇 |
皮肤病学 | 586篇 |
神经病学 | 1390篇 |
特种医学 | 1055篇 |
外科学 | 2221篇 |
综合类 | 62篇 |
一般理论 | 5篇 |
预防医学 | 577篇 |
眼科学 | 353篇 |
药学 | 1761篇 |
中国医学 | 255篇 |
肿瘤学 | 1262篇 |
出版年
2024年 | 12篇 |
2023年 | 123篇 |
2022年 | 446篇 |
2021年 | 678篇 |
2020年 | 307篇 |
2019年 | 456篇 |
2018年 | 529篇 |
2017年 | 406篇 |
2016年 | 604篇 |
2015年 | 826篇 |
2014年 | 962篇 |
2013年 | 1062篇 |
2012年 | 1564篇 |
2011年 | 1481篇 |
2010年 | 950篇 |
2009年 | 789篇 |
2008年 | 1118篇 |
2007年 | 1043篇 |
2006年 | 869篇 |
2005年 | 776篇 |
2004年 | 610篇 |
2003年 | 529篇 |
2002年 | 433篇 |
2001年 | 242篇 |
2000年 | 210篇 |
1999年 | 142篇 |
1998年 | 78篇 |
1997年 | 62篇 |
1996年 | 40篇 |
1995年 | 34篇 |
1994年 | 29篇 |
1993年 | 19篇 |
1992年 | 40篇 |
1991年 | 37篇 |
1990年 | 33篇 |
1989年 | 27篇 |
1988年 | 21篇 |
1987年 | 20篇 |
1986年 | 10篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1969年 | 2篇 |
1968年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
1.
2.
3.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
4.
Three‐Dimensional Echocardiographic Evaluation of Mitral Apparatus during Preload Manipulation in Patients with Hypertrophic Cardiomyopathy 下载免费PDF全文
Hyemoon Chung M.D. Ji Hyun Yoon M.D. Young Won Yoon M.D. Ph.D. Ji Young Chung B.N. Jung‐Joon Cha M.D. Jong‐Youn Kim M.D. Ph.D. Pil‐Ki Min M.D. Ph.D. Byoung‐Kwon Lee M.D. Ph.D. Bum‐Kee Hong M.D. Ph.D. Se‐Joong Rim M.D. Ph.D. Hyuck Moon Kwon M.D. Eui‐Young Choi M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(8):1261-1269
5.
6.
7.
The aim of this study was to design a new intravenous blood–gas exchange device and to estimate the design characteristics
of the device with a dimensionless function by using a substance that can be used instead of bovine blood. In addition, the
characteristics of oxygen transfer were estimated using empirical formulas and the reliability of the equations was ascertained
by comparing their output with an experiment performed using bovine blood. The dimensionless function was derived using distilled
water and bovine blood to estimate the oxygen transfer rate. Using the derived equations, the calculated oxygen transfer rates
for bovine blood and distilled water were similar for Reynolds numbers ranging from 0.7 to 7.0. Therefore, it is possible
to estimate the oxygen transfer rate in bovine blood, which is a non-Newtonian fluid, using distilled water, which is a Newtonian
fluid. Moreover, it was possible to verify the related equations because the oxygen transfer rate could be estimated using
the derived equations, according to the diameters of the various device modules. 相似文献
8.
Previously, we prepared two different monoclonal antibodies (mAbs) against human 4-1BB (CD137): an agonistic mAb BBK-1 and an antagonistic mAb BBK-2. In this paper, we describe the molecular cloning of these two mAbs and present comparisons of their amino acid sequences. cDNAs encoding the heavy (H) and light (L) chains of the two mAbs were cloned by screening of cDNA libraries constructed from hybridomas secreting these mAbs. Comparisons of amino acid sequences of the two mAbs showed that, while the constant regions of the H and L chains were identical between the two mAbs, the variable region showed 45% identity in H chains and 48% identity in L chains. This suggests that these two mAbs recognize different epitopes of 4-1BB and may have different effects on the activity of 4-1BB. 相似文献
9.
Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels. 总被引:2,自引:0,他引:2
We investigate the controlled release of lidocaine hydrochloride from the doped silica-based xerogels. In the xerogel preparation, tetraethoxysilane (TEOS), methyltriethoxysilane (MTES), and propyltriethoxysilane (PTES) are used as precursors, and a nonionic surfactant Igepal CO 720 is used as a dopant. The experimental results suggest that the release of lidocaine hydrochloride can be easily controlled by partially substituting TEOS with the organosilanes, and/or by adding the dopant. Adding the organosilane precursors lowers the release of both the drug and the surfactant in the order of TEOS, MTES/TEOS, and PTES/TEOS xerogels. The release from the PTES/TEOS xerogels is much lower than that from the other xerogels. The release of lidocaine hydrochloride is obviously suppressed by the addition of Igepal CO 720, while the release of Igepal CO 720 is slightly promoted by the addition of the drug. The overall release process is found to be diffusion-controlled, and the release behaviors can be well explained by considering the effects of the textual properties of the xerogels and the interactions among the drug, the surfactant, and the xerogel matrices. 相似文献
10.